Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration

BACKGROUND: Dialysis patients have been maintaining a high rate of cardiovascular morbidity and mortality. For this reason, it is to introduce necessary new technical advances in clinical practice. There is a relation between toxins retention and inflammation, mortality and morbidity. Medium cut-off...

Descripción completa

Detalles Bibliográficos
Autores principales: de Sequera, Patricia, Pérez-García, Rafael, Vega, Almudena, Martínez-Vaquera, Shaira, Acosta, Jesús Guillermo, Pérez Del Valle, Katia, Fernández-Lucas, Milagros, García-Rubiales, María Antonia, García-Herrera, Antonio Luis, Coll, Elisabeth, Mérida, Evangelina, Martínez-Miguel, Patricia, Castaño, Itziar, Gil-Casares, Beatriz, Garro, Julia, Maduell, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616438/
https://www.ncbi.nlm.nih.gov/pubmed/37915938
http://dx.doi.org/10.1093/ckj/sfad128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616438/
https://www.ncbi.nlm.nih.gov/pubmed/37915938
http://dx.doi.org/10.1093/ckj/sfad128

Ejemplares similares